High Throughput RT-qPCR and Transcriptomics: Powering the Next Generation of Drug Discovery

Biography

Timur Samatov, is a molecular biologist with a groundbreaking academic background. Getting his PhD from Moscow State University in 2006, he developed a pioneering cell-free genetic display technology. His postdoctoral work at the Max Planck Institute for Biophysical Chemistry focused on pre-mRNA splicing, where he developed high-throughput assays and conducted large-scale screens for splicing inhibitors.

Joining Evotec in 2016, Timur now leads a team driving high-throughput and high-resolution transcriptomics. As a Group Leader, he ensures team efficiency, individual growth, and a conducive work environment. Timur, an expert in transcriptomics, engages in strategic discussions with partners, defining support avenues and articulating data value.

Timur's team plays a crucial role in diverse disease-centric projects, actively progressing toward impactful medicines and therapies. 
 

Biography

Xavier Maréchal is a biochemist specializing in enzymology and RT qPCR. He earned his PhD from the University Pierre et Marie Curie in Paris in 2011. During his doctoral training and subsequent postdoctoral positions at the Institut Pasteur de Lille and the CEA (Commissariat à l'Énergie Atomique et aux Énergies Alternatives), he focused on drug discovery, developing high throughput screening (HTS) assays, running HTS campaigns, and evaluating compounds throughout the hit to lead process in close collaboration with medicinal chemists. 

Xavier joined Evotec in 2018, where he further specialized in the design and optimization of RT qPCR based HTS approaches for the identification of gene expression and mRNA splicing modulators. He now serves as a Team Leader within the High Throughput Screening and Biology department.